Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Raman, Gowri; Avendano, Esther E.; Chan, Jeffrey; Merchant, Sanjay; Puzniak, Laura

doi:10.1186/s13756-018-0370-9

Antimicrobial Resistance & Infection Control

Table 2 Baseline characteristics of studies in carbapenem-resistant P. aeruginosa

From: Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Author	Year	Design	Country	Case/Exposure	Control/Comparator	Total N	Age cases (Yr)	Age control (Yr)	Male cases (%)	Male control (%)
D’Agata (a) [17]	2006	CC, matched	USA, Italy	CRPA	Non-P. aeruginosa	82	61	60	73	44
DalBen [42]	2013	P, cohort	Brazil	MRAC and CRPA	Non-MRAC and non-CRPA	325	44	41	59	41
Djordjevic [43]	2013	P, cohort	Serbia	CRPA	CSPA	261	59.2	61.4	80.8	64.9
Eagye (a) [44]	2009	CC, control	USA	MRPA	MSPA	183	66.4	66.1	58.6	59.2
Eagye (b) [44]	2009	CC, control	USA	MRPA	Non-P. aeruginosa	182	66.4	57.4	58.6	50.9
Fortaleza (a) [45]	2006	CC, matched	Brazil	IRPA	Control (NR)	324	median 45	median 44	68.5	60.2
Furtado [46]	2009	CC, matched	Brazil	IRPA	Without IRPA	245	50	54	68.3	59.3
Furtado [47]	2010	CC, matched	Brazil	IRPA	Non-IRPA	295	54	54	70.7	56.5
Harris [50]	2002	CC, matched	USA	IRPA	Without IRPA	866	55.7	49.4	39.1	39.1
Harris [51]	2011	P, cohort	USA	IRPA	Non-IRPA	3146	56.7	55.7	61.9	56.7
Kohlenberg [54]	2010	CC, unmatched	Germany	CRPA	CSPA	33	median 60	median 44.4	53.3	72.2
Lautenbach [55]	2010	CC, unmatched	USA	IRPA	ISPA	2542	61 (total)	61 (total)	63.3	56.1
Lee [56]	2015	CC, matched	Taiwan	CRPA	All susceptible P. aeruginosa	75	61.6	62	48	48
Lin [57]	2016	CC, unmatched	Taiwan	CRPA	CSPA	164	66.6	63.5	72	67.1
Luyt [58]	2014	P, cohort	France	CRPA	CSPA	169	57.6	57.9	65	66
Onguru [59]	2008	P, cohort	Turkey	IRPA	ISPA	170	45.9	49.7	72	66.3
Pena [60]	2007	P, cohort	Spain	CRPA	CSPA	254	59.8	57.1	60	65
Pereira [61]	2008	CC, unmatched	Brazil	IRPA	ISPA	59	51.8	50.7	70	55
Tam [62]	2007	CC, unmatched	USA	CRPA	Pan-susceptible P. aeruginosa	51	50	64	33	73
Tuon [40]	2012	CC, unmatched	Brazil	CRPA	CSPA	77	46.4	49	75.9	70.8
Zavascki (a) [64]	2005	CC, unmatched	Brazil	IRPA	Non P. aeruginosa	186	58	51	60	53
Zavascki (b) [64]	2005	CC, unmatched	Brazil	IRPA	ISPA	158	58	51	60	66
Zhang [65]	2009	CC, unmatched	China	CRPA	CSPA	34	61	50	NR	NR

CC case-control, CRPA carbapenem-resistantP. aeruginosa, CSPA carbapenem-susceptible P.aeruginosa, ICU Intensive Care Unit, IRPA imipenem-resistant P. aeruginosa, ISPA imipenem-susceptible P.aeruginosa, MRAC meropenem-resistant Acinetobacter baumannii, MRPA meropenem-resistant P. aeruginosa, MSPA meropenem-susceptible P. aeruginosa, NR not reported,k P parallel, SICU Surgical Intensive Care Unit, YR year

Back to article page

ISSN: 2047-2994

Contact us

General enquiries: journalsubmissions@springernature.com